In this regard, an interesting model is represented by patients affected by familial hypobetalipoproteinemia type 1 (FHBL1) who manifest a low LDL‐C status as a consequence of the presence of inactivating variants in the APOB gene [7]. This evidence concerns the gene APOB and familial hypobetalipoproteinemia 1.